Search Results

DRNO found 9 articles matching your search.

Supreme Court to Rule on Pharma Data Law

In the US, Attorney General William Sorrell has filed a petition with the Supreme Court to review a decision previously made by a court in Vermont, which allows the collection and use of prescriber-identifiable data for marketing or promoting prescription drugs. More

Court Reverse for Opponents of Health Data Ban

In the US, the Supreme Court says it will not consider overturning a New Hampshire ban on the use of prescriber-identifiable data for marketing purposes. The law is contested by research and data firms including IMS Health and SDI / Verispan. More

CASRO and PMRG Weigh In Against Health Data Ruling

US research trade bodies CASRO and PMRG have given their support to health care MR specialists IMS Health, Inc. and Verispan LLC in their attempt to overturn a Court of Appeals ruling which would prevent them from using prescriber-identifiable data for marketing purposes. More

Health Data Firms Take Battle to Highest Court

IMS Health and SDI have petitioned the US Supreme Court to review a Court of Appeals ruling which would prevent them from using prescriber-identifiable data. More

Verispan Acquired by Healthcare Analytics Firm

In the US, healthcare data products and analytic services firm SDI has acquired pharma information provider Verispan. Terms were not disclosed. More

Province Bans Health Data Use for MR

In British Columbia, Canada, new legislation has been passed which according to Health Minister George Abbott, prohibits disclosure of information from electronic databases for market research and allows individuals access to their own health records and medical information. More

Verispan Launches Clinic Database

US pharma data provider Verispan has launched a Retail Clinical Database, providing details of pharmacy retail clinics and the healthcare practitioners associated with them. More

Court Win for Healthcare Info Firms

The U.S. District Court for the District of Maine has granted the preliminary injunction sought by three research and information firms to block enforcement of Maine's Prescription Restraint Law, LD-4. More

Pharma Veteran is New Verispan CEO

US healthcare information and research provider Verispan has appointed Wayne P. Yetter, former COO of IMS Health, as its new CEO. Yetter has also worked as CEO of Novartis Pharmaceuticals, Odyssey Pharmaceuticals and Astra Merck, and was most recently the Founder and President of Biopharm Advisory. More

Register (free) for Daily Research News